Entecavir is indicated for the treatment of CHB in adults with compensated liver disease and evidence of active viral replication and either elevated ALT/aspartate aminotransferase (AST ...

Entecavir (Baraclude), an inhibitor of hepatitis B virus DNA polymerase, is the latest approved antiviral agent for chronic hepatitis B. Researchers examined the efficacy of entecavir in two ...

This leaflet answers some common questions about ENTECAVIR VIATRIS. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

This drug is used with other HIV medications to help control HIV infection. Entecavir is used to treat long-term hepatitis B infection. Hepatitis B is an infection of the liver caused by the ...

Q: How long should I take Lamivudine? Do not stop taking entecavir without consulting your doctor. Stopping entecavir before treatment may worsen your hepatitis. This can happen during the first ...

Hepatitis B can develop resistance to older drugs such as lamivudine, but tenofovir and entecavir are usually effective over the long term. People with HIV co-infection should continue to use drugs ...

Entecavir and tenofovir are examples of common NAs. According to a 2020 research review, treatment with NAs can reduce disease progression and the risk of hepatocellular carcinoma, a type of liver ...

The U.S. Food and Drug Administration (FDA) recently responded to the safety evaluation of Antrodia cinnamomea mycelium, ...

by at least one grade after taking F351 in combination with entecavir. Gyre Pharmaceuticals expects to report topline data by early 2025. Plans to initiate a Phase 2a clinical trial in Non ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...

Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...